Articles related to CLINICAL STUDY

The study findings suggest that acalabrutinib and rituximab, a chemo-free therapy option, may offer a new standard of care for older, untreated MCL patients, with promising early complete responses. Yet, more data is needed to understand long-term safety and risk of relapse.

Discover the potential of xanthine dehydrogenase/oxidase blockers, such as allopurinol, in reducing the risk of neurodegenerative diseases. This large-scale study reveals intriguing associations and sets the stage for future research.

Findings from this trial may reshape how physicians perceive and prescribe testosterone-replacement therapy for middle-aged and older men with hypogonadism, with no substantial rise in major adverse cardiac events reported.

Explore the results of this study, which shed light on the underreported and frequently misunderstood phenomena of “brain zaps” during antidepressant withdrawal and its effects on medicine use and quality of life.

Explore the findings of a retrospective study examining treatment persistence in migraine patients using CGRP mAb therapies or Botox – the results may surprise you.

The novel finding that selective neuronal knock-out of STAT3 can potentially mitigate the progression of temporal lobe epilepsy underscores the necessity for further research into the JAK/STAT pathway’s involvement in epileptogenesis. This discovery may pave the way for more targeted, effective therapeutic strategies.